Every specimen collected in a hospital or clinic carries enormous weight: a cancer diagnosis, a life-changing prognosis, a decision that could alter treatment forever. Within Pathology, Histology and Cytology specimens are especially high-risk. They are irreplaceable once collected and often determine definitive care plans. Yet every year, healthcare facilities lose track of thousands of biopsy samples, tissue specimens, cytology preparations, and surgical materials.
These are not small mistakes. A lost tumor, a mislabeled biopsy, or a switched sample can force unnecessary surgeries, delay lifesaving treatments, and destroy patient trust.
In 2022, a patient at the University of Washington Medical Center Northwest had a bladder tumor removed. The tissue sample, which was critical for determining whether cancer remained, was lost before it could be tested. The patient endured repeated procedures and months of uncertainty. The incident led to a lawsuit and national headlines in The Washington Post and Becker’s Hospital Review.
A similar case in North Carolina, reported by WSOC-TV, involved a breast cancer patient whose tumor specimens disappeared after initial chemotherapy. With no way to determine if treatment had worked, she faced another six months of chemotherapy without any clear guidance.
In another case documented by SVMIC, a medical malpractice insurer, two patients’ prostate biopsy specimens were switched. One man underwent an unnecessary prostatectomy, while the actual cancer patient went untreated. DNA testing later revealed the devastating mix-up.
These stories show how specimen errors, though statistically rare, can have catastrophic consequences for both patients and hospitals.
Takeaway: Even one misplaced tumor specimen can cascade into repeated surgery, delayed treatment, and significant legal risk.

Specimen handling involves a complex chain of custody: collection in procedure rooms, operating rooms, and specialty clinics; labeling; temperature-appropriate storage; courier handoff; transport; accessioning; and processing in the Histology and Cytology labs.
Every hand-off introduces risk:
Many healthcare facilities still rely on manual logging or barcode-only systems that depend heavily on human diligence. In high-volume environments, this leaves too many opportunities for specimens to be misplaced, swapped, delayed, or temperature-compromised.
Peer-reviewed studies show that specimen provenance errors (SPCs), including swaps and contaminations, affect nearly 1% of biopsies.
Type 1 (swaps): 0.26%
Type 2 (contaminations): 0.67%
(Source: Pfeifer JD et al., 2013; American Journal of Clinical Pathology)
With millions of biopsies performed each year in the United States, that fraction translates to tens of thousands of compromised specimens. A follow-up study in the Journal of Urology estimated that SPCs lead to about 4,500 false diagnoses and nearly $880 million in avoidable costs annually. Even more troubling, these figures likely understate the problem because many incidents are caught internally, settled confidentially, or never reported.

Before a specimen ever reaches Histology or Cytology, pre-analytic controls protect integrity:
Explore the OR-to-lab workflow guide for an example of configured custody checkpoints.
Modern hospitals and clinics are adopting RFID-enabled specimen tracking to close custody and temperature gaps—especially for Histology and Cytology workflows where specimens are irreplaceable.
Unlike barcodes, RFID does not require line-of-sight scanning. It works automatically, even through sealed specimen containers while reducing dependence on manual steps and resulting in fewer misses and better pre-analytic compliance.
Barcode: requires manual scanning, line-of-sight, and multiple human touches
RFID: automatic, non-line-of-sight, reads through bags/containers, hands-free checkpoints
Most barcode-only systems do not record container-level temperature exposure during courier legs or staging. RFID-enabled temperature logging closes this gap, ensuring both custody and integrity are captured in one unified record.
At-a-glance differences for custody, recovery, and cold chain
| Capability | Passive RFID | Barcode |
|---|---|---|
| Reads many items at once | ✓ Yes | X No |
| Line-of-sight required | X No | ✓ Yes |
| Automated custody at handoffs | ✓ Yes | X Manual Scans |
| Last-seen location for recovery | ✓ Yes | X No |
| Receiving auto-reconcile (expected vs. received) | ✓ Yes | X No |
| Works through sealed containers | ✓ Yes | X No |
| Cold-chain result recorded with custody | ✓ Yes | Manual Step |

A single lost Histology or Cytology specimen can trigger million-dollar claims, reputational damage, and profound harm to the patient. RFID-based chain-of-custody, coupled with simple temperature checks for lab boxes and coolers, creates a closed loop across collection, staging, courier legs, and lab receipt.
By modernizing specimen chain-of-custody workflows, healthcare organizations can:
Reach out to schedule a consultation or call (425) 438-2533 to explore RFID specimen tracking for your hospital or clinic.
To see how healthcare systems are closing the loop on specimen tracking with real-world results, read our in-depth article, "No Specimen Left Behind: Passive RFID Specimen Tracking for Hospitals and IDNs."
This companion piece explains how passive RFID works within complex environments—from collection to Histology and Cytology—so no specimen, and no patient, is left behind.
Browse more automation and asset tracking resources for healthcare here.
Need expert guidance?
Call us (425) 438-2533
